| The molecular mechanisms and therapeutic potential of EZH2 in breast cancer S Adibfar, M Elveny, HS Kashikova, MV Mikhailova, P Farhangnia, ... Life sciences 286, 120047, 2021 | 20 | 2021 |
| SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy P Farhangnia, SM Ghomi, S Mollazadehghomi, H Nickho, M Akbarpour, ... Frontiers in Immunology 14, 1174138, 2023 | 19 | 2023 |
| Bispecific Antibodies Targeting CTLA-4: Game-changer Troopers in Cancer Immunotherapy P Farhangnia, S Mollazadeh Ghomi, M Akbarpour, AA Delbandi Frontiers in Immunology 14, 1155778, 2023 | 18 | 2023 |
| The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis … G Hajiluian, SJ Karegar, F Shidfar, N Aryaeian, M Salehi, T Lotfi, ... Phytomedicine 121, 155094, 2023 | 17 | 2023 |
| Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities AR Safdarian, K Momenzadeh, F Kahe, P Farhangnia, N Rezaei Clinical Case Reports 9 (1), 461-464, 2021 | 16 | 2021 |
| Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials P Farhangnia, S Dehrouyeh, AR Safdarian, SV Farahani, M Gorgani, ... International Immunopharmacology 109, 108786, 2022 | 12 | 2022 |
| Current and future immunotherapeutic approaches in pancreatic cancer treatment P Farhangnia, H Khorramdelazad, H Nickho, AA Delbandi Journal of Hematology & Oncology 17 (1), 40, 2024 | 10 | 2024 |
| Immunological Tolerance P Farhangnia, M Akbarpour Encyclopedia of Infection and Immunity 1, 206-220, 2022 | 10 | 2022 |
| Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives P Farhangnia, M Akbarpour, M Yazdanifar, AR Aref, AA Delbandi, ... Expert Review of Clinical Immunology 18 (12), 1217-1237, 2022 | 9 | 2022 |
| Bispecific Antibodies in Targeted Cancer Immunotherapy P Farhangnia, AA Delbandi, M Sadri, M Akbarpour Handbook of cancer and immunology, 1-46, 2023 | 8 | 2023 |
| Handbook of Cancer and Immunology P Farhangnia, AR Safdarian, M Akbarpour Springer, 2023 | 7 | 2023 |
| The association between CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma M Panahi, F Rezagholizadeh, S Mollazadehghomi, P Farhangnia, ... Cancer Treatment and Research Communications 35, 100699, 2023 | 7 | 2023 |
| Potential antiviral immune response against COVID-19: Lessons learned from SARS-CoV M Akbarpour, L Sharifi, AR Safdarian, P Farhangnia, M Borjkhani, ... Coronavirus Disease-COVID-19, 149-167, 2021 | 7 | 2021 |
| Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind … S Jafari Karegar, N Aryaeian, G Hajiluian, K Suzuki, F Shidfar, M Salehi, ... Frontiers in Nutrition 10, 1238846, 2023 | 6 | 2023 |
| Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis P Farhangnia, M Noormohammadi, AA Delbandi Reproductive Health 21 (1), 61, 2024 | 4 | 2024 |
| Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma F Rezagholizadeh, F Tajik, M Talebi, SR Taha, M Shariat Zadeh, ... Frontiers in Immunology 15, 1283364, 2024 | 4 | 2024 |
| Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy A Aghamajidi, P Farhangnia, S Pashangzadeh, AR Damavandi, R Jafari Cancer Cell International 22 (1), 327, 2022 | 4 | 2022 |
| Current clinical landscape of immunotherapeutic approaches in pancreatic cancer treatment P Farhangnia, S Mollazadeh Ghomi, S Mollazadehghomi, AA Delbandi Gastrointestinal Cancers: An Interdisciplinary Approach, 327-380, 2023 | 3 | 2023 |
| The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism P Farhangnia, AA Delbandi, N Aghamohammadi, AR Safdarian, ... Handbook of Cancer and Immunology, 1-50, 2023 | 3 | 2023 |
| Indoleamine 2, 3-Dioxygenase (IDO) and Cancerous Cells AR Safdarian, P Farhangnia, N Rezaei Handbook of Cancer and Immunology, 1-23, 2023 | 2 | 2023 |
Ali-Akbar DelbandiIUMSVerified email at iums.ac.ir
